The DEA (the US drug enforcement agency) will likely put out an official public statement in 2026 making clear that ibogaine — a powerful psychedelic being explored as an addiction treatment — is still illegal under federal law, regardless of what individual states allow. States like Texas are starting to authorize ibogaine programs, and the DEA has historically pushed back when states get too far ahead of federal law.
As Texas-model state ibogaine programs spread, DEA faces institutional pressure to go on the record — silence reads as forbearance, and the cannabis precedent showed the agency what forbearance becomes. Note: the original compound prediction bundled this with the no-rescheduling claim; that clause is now split into a separate prediction, and confidence here is lowered to reflect only the statement claim, which depends on discretionary agency communications. Resolution criteria: resolves YES if DEA (via press release, official letter, congressional testimony, or Federal Register notice) publicly asserts that state ibogaine programs do not exempt participants from the CSA, by 2026-12-31.